What is Symmetry Surgical Shares Outstanding (EOP)?
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Symmetry Surgical's shares outstanding for the quarter that ended in Sep. 2014 was 37.1 Mil.
Symmetry Surgical's quarterly shares outstanding
increased
from Jun. 2014 (36.6 Mil) to Sep. 2014 (37.1 Mil).
It means Symmetry Surgicalissued new shares from Jun. 2014 to Sep. 2014 .
Symmetry Surgical's annual shares outstanding
declined
from Dec. 2012 (36.4 Mil) to Dec. 2013 (36.3 Mil).
It means Symmetry Surgicalbought back shares from Dec. 2012 to Dec. 2013 .
Symmetry Surgical Shares Outstanding (EOP) Historical Data
The historical data trend for Symmetry Surgical's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Symmetry Surgical's Shares Outstanding (EOP)
For the Medical Devices subindustry, Symmetry Surgical's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Symmetry Surgical's Shares Outstanding (EOP) Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where Symmetry Surgical's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Symmetry Surgical Shares Outstanding (EOP) Related Terms
Thank you for viewing the detailed overview of Symmetry Surgical's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:RZV has been successfully added to your 